Introduction
The elective vaginal delivery of breech presentation infants has become less frequent due to the concern of clinicians about perinatal morbidity and mortality. Thus, cesarean delivery for breech presentation has increased to reduce or avoid fetal trauma and/or asphyxia [5] . However, the risks of vaginal breech delivery can be avoided if the fetus is manipulated from breech to cephalic presentation by external cephalic version (ECV) [6, 9, 13, 14, 16, 17, 18, 20, 21] . Randomized prospective studies have indicated that 3rd trimester ECV performed with tocolysis following real time ultrasound and cardiotocography screening, involves minimal fetal risk and is 60-90% successful [9, 18] . As the role for late third trimester ECV is not established in pregnancies with breech presentation, we initiated a prospective clinical trial of ECV to evaluate the safety and utility of the procedure. Our experience constitutes the basis for this report.
Materials and methods
101 patients with normal pregnancy, from private and university services were referred for ECV (figure 1) and prospectively managed by protocol. Entry requirements were breech presentation at > 35 weeks from the last menstrual period and normal gestation. Patients excluded from consideration for trial included those with: 1) a fixed, engaged presenting part; 2) multiple gestation; 3) serious medical disorders of pregnancy (e. g. insulin-requiring diabetes, hypertension, etc.); 4) known or suspected fetal anomaly; and 5) known or suspected serious pregnancy complications (e. g., premature membrane rupture, abruptio placentae etc.). Initial screening was performed by clinicians who then referred selected patients to our research unit for the ECV protocol. A screening real time ultrasound examination and an unstressed cardiotocogram (NST) was performed. The NST was classified as reactive and acceptable if two or more fetal heart rate accelerations of > 15 bps for > 15 seconds was observed over 20 minutes. Gestational age was established by menstrual dating and ultrasonic examination based on biparietal diameter, head/body ratio and long bone length. Discrepancies exceeding + 2 weeks were reconciled by pediatric examination of the neonate utilizing DUBOWITZ criterion with reassignment of dating if appropriate.
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Following informed consent, 0.25 mg. of terbutaline sulfate was administered subcutaneously. Only a single injection was given. Manipulations were performed 30 minutes later. Mineral oil was applied as a maternal abdominal lubricant. Versions were performed with the patient supine in TRENDELENBERG'S position. A headover-heels technique with the operation at the patient's right side was preferred. Back-flips as described by SALING and MÜLLER-HOLVE [14] were performed if the initial procedure failed. Firm, but slow movements proved most successful. Following manipulations, the fetal heart was ultrasonically visualized, the rate observed, and fetal position confirmed. Finally, an additional electronic fetal heart rate monitoring was performed to assure fetal well being.
If two attempts in each direction failed to achieve version or the patient proved intolerant to manipulation, the procedure was terminated. Rh negative women were administered immunoglobulin if any manipulations, either successful or unsuccessful had been performed. KLEIN-HAUER-BETKE examinations were not performed. Following the procedure the patients were rested in left lateral recumbency until the cardiotocography was judged normal, thereafter they were discharged to home. Subsequent management was by standard clinical procedures of the responsible clinician.
Date was analyzed by Chi square or t-test analysis with p < 0.05 accepted as the level indicating significance.
Results
We attempted version on 85 of 101 patients. Initial cephalic presentation [11] , marked oligohydramnios [3] , encephalocele [1] , and a nonreactive, suspicious initial electronic monitoring tracing [1] led to candidate rejection (figure 2). In 53/85 cases (62.5%) ECV was successful.
Our requirements for gestational age for trial of ECV were based on clinical criteria, i. e., menstrual dating. We subsequently discovered that using 35 weeks as a minimum .gestational age for referral resulted in a patient group with the eventual assignment of gestational ages ranging from 33 to 41 weeks (figure 3). When the date was evaluated for mean maternal age, gestational age and eventual delivery weightall were found to be unrelated to ECV success. However, parity was observed to be a significant factor (tables I, II). Four patients (4/85 = 4.7%), 2 from each group, were lost to follow-up (figure 2). One gravida could not be contacted, two women had left the state, and one the country prior to delivery.
Fifty percent of the ECV failure patients subsequently delivered by cesarean section. However, abdominal delivery was required in only 9.8% (5/51) of those cases in which version had been successful. Of interest, in three cases spontaneous version to cephalic presentation occurred after failed ECV (3/30 = 10.0%) (table  III) . 
Discussion
External manipulation of the fetus can convert 60 -90% of breech presentations to cephalic depending upon technique, the skill of the operator, use of tocolysis, and the population selected for trial [6, 7, 9, 13, 14, 16, 18, 20, 21] .
The relative influence of gravity, uterine shape, or placentation in eventual fetal polarity is not established [15, 19] . At the beginning of the 3rd trimester, 20 -30% of fetuses present by the breech. However, as gestation proceeds, enlargement of the fetus, diminution of amniotic fluid volume, and adjustment of the uterus predispose to cephalic presentation. Studies of fetal life note that the infant spontaneously assumes a cephalic presentation by the 34th week of gestation in all but 2-4% of normal pregnancies [19] . Thus, if version is attempted in the early 3rd trimester it is often easy, but frequently unnecessary, and re-version may occur. However, once a pregnancy passes into the late 3rd trimester, spontaneous version is uncommon (< 15%), and the probability of the existing presentation persisting to term is high. These facts must be considered in the critical evaluation of the role of ECV in the obstetrical management of malpresentation.
In this study, 16 of 101 patients were excluded from trial of version by the combined results of real time ultrasonic scanning and EFM. In one case, with spontaneous contractions, suspicious decelerations occurred in a pregnancy in which the fetus was found to be growth retarded. In the other instance, a large fetal encephalocele was observed on the initial ultrasound scan. On initial scanning 11 fetuses were found to be in cephalic presentation and version was not attempted. Marked oligohydramnios led to the exclusion of 3 additional cases early in the course of the study. Yet, one serious fetal anomaly was missed. We evaluated and successfully verted a fetus that subsequently proved to Transient fetal heart decelerations frequently accompany version attempts and were observed in this series [16] . In some instances maternal symptoms implied a supine hypertensive syndrome likely exacerbated by the abdominal manipulations of version. In most circumstances, however, the changes were of unestablished cause but were likely due to transient cord compression. In our series, re-version for persisting fetal bradycardia was never necessary and in no instance was acute delivery required for conditions arising from the procedure. However, one compound (head/arm) presentation occurred following version. In this case, dystocia ensued during labor and operative delivery was necessary. Such complications, albeit uncommon, have been previously observed [1] .
The single serious fetal complication in this series, meconium aspiration, occurred in a vaginally delivered breech infant. An unsuccessful version attempt had occurred 16 days previously. While meconium was present in 8 additional cases, in none was it associated with fetal distress. A larger series is needed to establish any association between the manipulations of version and meconium passage. The other complications observed, cord prolapse, and a marginal abruptio placentae occurred more than 10 days after ECV and are difficult to ascribe to the procedure.
Clinically, failure to elevate the presenting part was the most consistent cause of ECV failure. We could not discern specific ultrasonic findings that others have reported [7, 10, 20] predicting success in version, except engagement of the breech. In our series attempted vaginal manipulations to dislodge an engaged breech were in all but one instance unsuccessful as well as uncomfortable for the patient. In addition, neither placental locale nor low amnionic fluid volume (unless marked oligohydramnios was present) modified our version protocol. None of the gravids examined in this series had clinical or ultrasonic evidence of placentation suffi-ciently low lying to permit the diagnosis of placenta previa. Further, we did not observe differences in success based on placental localization.
Initially, we utilized terbutaline tocolysis only in cases in which initial manipulation failed to achieve easy version. However, we soon discovered that betamimetic assisted version was easier for both patient and operator, and thereafter, we administered tocolytics routinely (overall in 43/85 or 50.5%). Betamimetics are not without serious complications, but neither we nor others have observed complications from acute administration for ECV [6, 14, 18] . Terbutaline was chosen because of our successful prior experience with this agent; the route of administration by convenience and economy.
Due to the fact that our patients frequently traveled long distances for the procedure and with uncertainties of patient follow-up, we routinely administered immune globulin to all Rh negative patients with an ECV attempt [9, 11, 12] . In series in which KLEINHAUER-BETKE studies have been performed, 4 -28% of version patients have shown evidence of measurable fetomaternal bleeding [8, 16] .
Based on our experience, factors important to the success and safety of late third trimester version include:
1) Operator experience and careful patient selection, 2) The use of firm but smooth movements during manipulation, 3) Screening by both real time ultrasound and electronic fetal heart rate monitoring, 4) The use of tocolysis, 5) A setting permitting prompt intervention if required.
In sum, while the numbers involved in this trial are limited, we conclude that major risks do not accompany late 3rd trimester version if reasonable care is taken and careful pre-attempt fetal evaluation is performed. However, practitioners and patients need to remain aware that fetal manipulations cannot invariably be free from complications [1, 2, 3, 4, 8, 12] . Thus, it seems prudent to carefully evaluate the fetus both anatomically as well as biophysically prior to an attempt at version in a setting where intervention, if indicated, is possible.
Summary
Eighty-five normal women underwent external cephalic version (ECV) for breech presentation in the late 3rd trimester (figures 1, 2). The protocol included real time ultrasonic scanning and pre-and post-procedure electronic fetal monitoring. Subcutaneous terbutaline sulfate (0,25 mg.) was administered to (43/85 or 50.5%) of ECV candidates and rendered the procedure easier for patient and operator. A single operator, head-over-heels technique assisted by supine TRENDELENBERG'S position was used. Rh negative women were routinely administered 300 meg of immune globulin. Successful ECV (53/85, 62.5%) was related to maternal parity, but not tp gestational age nor eventual delivery weight (tables I, II). There were no acute maternal or fetal complications referrable to ECV. One neonatal loss occurred due to a lethal congenital cardiac anomaly (table IV) . In this series only engagement of the breech was reliable in predicting ECV failure. Fifty of 51 (98.1%) successfully verted women delivered a cephalic presentation infant at term. Cesarean section was performed in 5/51 of these patients (9.8%) for routine obstetrical indications. In one case, compound presentation at term resulting in dystocia and eventual cesarean section was believed related to prior successful version. In contrast, 15/30 (50%) of the ECV failure patients went on to operative delivery despite a liberal institutional policy toward term vaginal breech trials. In addition, the only serious fetal complication in this series, meconium aspiration, occurred in a vaginally delivered breech infant (tables III, IV). It is unlikely that late 3rd trimester ECV will impact on our overall rate of cesarean delivery. In North America prematurity is the greatest risk factor in malpresentation and our policy increasingly is to permit attempts at term breech vaginal delivery. Nonetheless, ECV deserves serious consideration. When successful, ECV avoids the costs and/or risks of either cesarean section or vaginal trial of breech. As opposed to version practiced earlier in gestation, the merit of late 3rd trimester ECV is that more than 80% of spontaneous versions will have occurred by the time the procedure is attempted. Thus, most successful late version procedures occur in cases -r where spontaneous conversion is unlikely. In addition, babies successfully verted late in gestation are unlikely to spontaneously revert to breech (1/51 or 2% in our series).
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Under the protocol described herein, and in a limited series of patients, we have found late 3rd trimester ECV 62.5% successful and clinically safe. Quatre-vingt cinq femmes normales ont subi une version par manoeuvres externes (VME) a la fin du troisieme trimestre pour une presentation du siege (figures l, 2). Le protocole comprenait une echographie en temps reel et un enregistrement du rythme cardiaque foetal avant et apres les manoeuvres. On a administre en sous-cutane du sulfate de terbutaline (0.250 mg> a 43 canditates a la VME sur 85 (50,5%) ce qui facilitait les manoeuvres pour les patientes et pour Foperateur. Un seul Operateur utilisait la technique de la tete sur les talons aide d'une position de trendelenbourg. Les femmes rhesus negatif ont re$u systematiquement 300 mcg de gammaglobuline. Les succes de la VME (53/85; 62,5%) sont correles a la parite maternelle, mais ni ä Tage gestationel, ni au poids de naissance (tableaux I, II). II n'y a pas eu de complication aigüe maternelle ou foetale implicable ä la VME. Un deces neonatal est survenu, secondaire ä une anomalie cardiaque congenitale lethale (tableau IV). Dans cette serie, seul Fengagement du siege etait correle ä la prevision d'un echec de la VME. Cinquante des 51 (98,1%) ayant eu une version efficace ont donne naissance, ä terme, ä un enfant en presenta-tion cephalique. Chez ces patientes, une cesarienne ä ete pratiquee 5 fois/51 (9,8%) pour des indications obstetricales de routine. Dans un cas, un procubitus d'un membre a terme a entraine une dystocie et on a considere la cesarienne comme secondaire a la version efficace anterieure. A Finverse 15/30 (50%) des patientes ayant eu un echec de la VME ont subi une cesarienne malgre une attitude institutionelle liberale face aux sieges ä terme. En outre, la seule complication foetale severe dans cette serie, ä savoir une inhalation meconiale, est survenue chez un enfant en presentation du siege ne par voie vaginale (tableau III, IV). II est peu probable que la VME a la fin du troisieme trimestre influencera le taux global de cesarienne en Amerique du Nord et ceci pour deux raisons: la premiere est que la prematurite est encore le facteur de risque le plus important pour la presentation defavorables, et la deuxieme est du ä une politique plus liberale de Faccouchement du siege par voie basse a terme. Neanmoins, la VME mnrite une consideration importante. Lorsqu'elle reussit la VME evite le coüt et/ou les risques de la cesarienne et de Paccouchement du siege par voie basse. A Foppose de la version pratiquee plus tot au cours de la grossesse, le merite de la VME a la fin du troisieme trimestre est que plus de 80% des versions spontanees auront deja eu lieu au moment de la tentative. Ainsi, beaucoup de versions efficaces par monoeuvres externes tardives surviennent dans des cas ou la version spontanee est peu probable. En outre, les foetus verses en presentation cephalique tardivement au cours de la grossesse ont peu de risque de se retourner spontanement en siege (I/ 51 ou 2% dans notre serie). Selon le protocole decrit ci-dessus et dans une serie limitee de patientes, nous avons trouve que la VME ä la fin du troisieme trimestre ä 62,5% de succes et qu'elle est cliniquement sans danger.
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